Sandoz Bolsters its European Essential Medicine Manufacturing Capacity
In the wake of the COVID-19 crisis and the subsequent strain placed on medicine supply chains in Europe, Sandoz – the generics arm of global giant Novartis – has moved…
Address: ‘EuroPlaza: Am Europlatz 2 / Geb. G
A-1120 Wien
,Austria
Tel: 0043-(0)171728313
Web: http://www.hospira.at/german/default.aspx
Hospira brings proven leadership to the hospital products marketplace. With its more than 70-year history of excellence, Hospira is built on a solid and distinct platform. The Austrian subsidiary was built in January 2011. Before that, Hospira´s products were sold in Austria over years via distribution partners.
Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety.
Hospira’s Vision: Advancing Wellness…through the right people and the right products
Hospira’s vision guides everything the company does. ‘Advancing’ focuses on Hospira’s progressive, positive and purposeful approach as it looks to the future. ‘Wellness’ demonstrates a broad commitment to healthcare, supported by our wide variety of products that help improve the well being of patients around the world. Wellness also refers to the overall well being of Hospira’s customers, employees, shareholders and communities.
The ‘right people’ — Hospira’s employees — are a talented group of dedicated, customer-focused, entrepreneurial individuals who are committed to working under the highest standards of integrity and ethics. Hospira’s broad portfolio of products — the ‘right products’ — provides quality, reliability and cost-effectiveness.
Hospira’s Commitment
The company has an unwavering commitment to:
• Its customers and patients, delivering on its promise by serving their needs with integrity, trust and innovation.
• Its employees, by embracing diversity of thought and cultural perspective, and fostering an environment of empowerment, fairness and respect.
• Its shareholders, by safeguarding their investment and providing a fair return.
• Its communities, acknowledging its social responsibility through active citizenship and thoughtful giving.
As the world leader in specialty generic injectable pharmaceuticals, Hospira Austria offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions with a double digit growth over the last two years. Its broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
In the wake of the COVID-19 crisis and the subsequent strain placed on medicine supply chains in Europe, Sandoz – the generics arm of global giant Novartis – has moved…
Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian affiliate within the global group, organizational restructuring, and the receptiveness of Austria to UCB’s innovative…
Joy Ladurner, co-director of the NKSE (National Coordination Center for Rare Diseases) in Austria, discusses the rationale behind Austria’s prioritization of rare diseases and its leading role in the field.…
Alexander Biach, chairman of the Main Association of Austrian Social Security Institutions, discusses handling the responsibility for Austria’s Europe-leading social security coverage, current inefficiencies that need to be ironed out,…
Gerhard Hirczi of the Vienna Business Agency and Peter Halwachs of LISAvienna describe Vienna’s impressive footprint in the life sciences, its positioning as the start-up hub for Central and Eastern…
Peter Wimmer, country manager of Angelini Austria and Germany, discusses the tailored long-term strategy that this exciting Italian pharmaceutical company is implementing to establish a boutique portfolio and the importance…
Christoph Wahl and Gerlad Weirowski of DHL Global Forwarding Austria discuss the significance of the Austrian affiliate being chosen as lead office for CEE and the company’s life sciences and…
Christoph Sauermann, managing director of Mediclass, an innovative healthcare center, discusses how the complexities of the Austrian healthcare system can be solved through primary healthcare centers, such as Mediclass. Furthermore,…
Rudolf Widmann, CEO and founder of AOP Orphan, the first rare disease-specific European company, discusses the overriding goal to ensure rare disease patients are matched with the correct treatments and…
Barbara Rangetiner and Josef Weinberger of the Austrian affiliate of Octapharma, the largest privately owned human protein products manufacturer in the world, discuss the strategic significance of Austria to the…
Dr. Wolfgang Harrer, regional manager of Chiesi Central and Eastern Europe (CEE), discusses the challenges of managing the region’s diverse cultural differences and the importance of CEE within global operations.…
David Kasper, CEO of ARCHIMEDlife, an innovative Austrian company focused on novel laboratory diagnostics, discusses the innovative solution of a dried blood sample in daily routine diagnostics and novel assays…
See our Cookie Privacy Policy Here